Pete went in on Wednesday for his first infusion of the Dacarbazine (DTIC) and Doxil combination. We met with Dr. W beforehand and he again went over some of the possible side effects of the Doxil, the most common of which is hand-food syndrome. He explained that the skin of the hands and feet may crack and/or blister and that the recommended remedy is to start applying moisturizer before there are any signs of a problem. While Pete was being infused I visited a friend of mine who lives in the next town and we went out for a bite to eat and caught up on things over a few cups of coffee; then I went back to wait for Pete to finish up.
I was standing in the waiting room while Pete was setting up his next appointment when the phlebotomist walked by and said, "Will you be here with him again tomorrow?". It caught me off guard, so I just answered, "I don't know." When we got in the elevator, Pete told me that he would be having two more days of infusion. He didn't seem really happy about this and I know it came as a surprise to me.
Thursday's appointment was scheduled for 1 PM, and Pete said he would go up by himself and that he was feeling pretty good, except for the pain in his scapula/chest areas. Bruce and I had to run some errands, so left shortly after Pete walked out the door to go to his appointment. A few hours later I got a strange text from Pete, asking where we were. It was strange because the only way he would know we weren't at home would be if he called our landline, which he never does, or he was home.
It turned out he was home. Once again there was a problem with getting a blood return on his port (see "2+1 Days of Chemo" - March 13, 2010). As a result, he had an appointment for Friday at 7:30 AM at one of the local hospitals to have the port cleared, then over to Dr. W's office for the second infusion, and that's exactly what he did today.
Since Dr. W's office does not have hours on Saturday, he'll be going back to the hospital tomorrow, to the day-stay area, for the third infusion.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment